Thursday, May 7, 2026

Progressive and Conservative Inter-Korean Policies Both Rooted In “East-West German Basic Treaty”: An End to Consumptive Debates Is Needed

The Two States Theory debate highlights ideological divides without practical solutions, misusing the East-West Germany treaty as justification.

Health

CG Bio Group Launches Acellular Dermal Matrix-based Product Reallo Inject Fine

CG Bio launches Reallo Inject Fine, an acellular dermal matrix product, enhancing usability for medical professionals and expanding applications.

Ceragem Launches Global Standard for AI Home Healthcare, Accelerates Data Platform Push

Ceragem's new ISO/IEC report sets international standards for integrating home healthcare devices, focusing on user well-being and safety.

Hugel Participates AMWC ASIA & TDAC 2026 at the Taipei International Convention Center, Taiwan

Hugel targets Taiwan's aesthetic market, showcasing products at AMWC ASIA & TDAC 2026, while expanding in Indonesia with educational programs.

L&K BioMed Showcases Innovative Products at the AANS Conference in Texas

L&K BioMed showcased its products at the AANS conference, receiving positive feedback and interest for its cervical products, aiming to expand in the U.S. market.

Seers Signs $14.7 Million Contract with UAE to Supply 105,000 Units over 3 Years

Seers signs a major deal for mobiCARE devices in the UAE, aiming for 50% growth and expansion into Vietnam and beyond.

Yonsei University Develops AI Platform for Early Autism Screening and Treatment

Yonsei University is developing an AI platform for autism screening, aiming for early detection and practical use in clinical settings.

Mediwhale’s DrNoon Receives CE MDR Certification in Europe for Cardiovascular Risk Prediction

Mediwheel's retinal AI solution 'DrNoon' has received CE MDR certification, enhancing its credibility in the European medical device market.

Korean MSD Partners with 13 Biotech Firms to Act as Global Collaboration Hub

Korean MSD held an Open Innovation Week to enhance collaboration with local biotech firms, aiming for technology exchanges and joint research.

Matica BIOLABS Signs CMO with Jeongjin Bioscience for Mesenchymal Stem Cell Culture Media Production

Matica BIOLABS partners with Jeongjin Bioscience for stem cell media production and expands operations with Humic for drug development.

GC Cell Secures Japanese Certification for the Manufacture of Specific Cell Processing Products

GC Cell receives final certification from Japan for cell processing products, validating its manufacturing and quality systems for regenerative medicine.

AITRICS Showcases Clinical Value and Real-World Applications of AITRICS-VC (VitalCare) Solution

AITRICS showcased its VitalCare AI solution for predicting critical health conditions at a symposium, enhancing clinical decision-making.

Daewoong Pharmaceutical Completes Global Phase 2 Trials for First-in-Class IPF Treatment

Daewoong Pharmaceutical completes patient recruitment for a Phase 2 trial of Bersiporocin, a potential treatment for idiopathic pulmonary fibrosis.

Tailored Chemotherapy Boosts Survival Rates for Elderly Colon Cancer Patients

A study reveals tailored treatment for elderly colon cancer patients boosts survival rates, challenging age-based treatment limitations.

HLB Group Appoints Yang Eun-young President of Bio Business Development Division

HLB Group appoints Yang Eun-young as President of Bio Business Development, focusing on global partnerships and commercialization strategies.

VAIM Hosts JUVELOOK and juveàcell Symposium in Busan for Aesthetic Medicine and Treatment

VAIM hosted the JUVELOOK & juveàcell Symposium in Busan, showcasing advancements in aesthetic medicine for healthcare providers.

Curocell’s RIMQARTO®: The First CAR-T Therapy in Korea, with Plans for Global Release

Curocell aims to lead in CAR-T therapies with RIMQARTO's approval, focusing on solid tumors and global expansion strategies.

Qurient Mocaciclib’s CDK7 Inhibitor is Revolutionizing High-Risk Pediatric Brain Cancer Therapy

Qurient's Mocaciclib shows promising results for pediatric brain tumors, enhancing survival and overcoming treatment barriers.

AITRICS: “Medical Artificial Intelligence (AI) is No Longer a Choice”

Medical AI must prove its real-world value. AITRICS focuses on tools that enhance decision-making and integrate into healthcare workflows.

i-SENS CareSens Air 2: The Future of Blood Sugar Monitoring in 2026

i-SENS is expanding globally with the CareSens Air 2, enhancing digital features for better diabetes management and market competitiveness.

Top News

- Our Sponsors Ad -

Follow us